Avendus Capital has considerable experience and a strong network of global relationships in the Life Sciences sector. The Life Sciences Group consists of professionals with many years of investment banking and operating experience in the industry.
The Life Sciences group delivers strategic financial advisory to clients across the spectrum of Health Care, Specialty Chemicals and Agro Chemicals sub-sectors which include the following sub-segments:
- Pharmaceutical Drugs including Branded Formulations, Generics, Ethical Drugs, Bio-pharmaceuticals and Vaccines
- Contract Research & Manufacturing Services (CRAMS) including Clinical Research (CROs)
- Hospitals and Pathology Labs
- Medical Technology including diagnostic equipment and medical devices
- Agro-chemicals and Seeds
- Specialty Chemicals
An illustrative selection of transactions in the Health Care industry are listed below:
- Buyside advice to Jubilant Organosys in its acquisition of Target Research, a CRO for US$ 34 mm
- Private equity syndication of US$ 50 mm for Famycare, the world’s largest manufacturer of generic oral contraceptive pills
- Private equity syndication for Metropolis Labs, a pathology lab chain from ICICI Ventures
To know more about the Life Sciences group, write to healthcare@avendus.com